A randomized trial shows that a new thrombolytic agent reduces total mortality by 30% in the first 30 days after a suspected myocardial infarction compared with a placebo (p = 0.002). Which of the following questions would be the most important to have answered? a. Was the trial blinded? b. What was the power of the study? c. What happened to surviving patients in the next year? d. What percentage of patients in each group actually had a myocardial infarction? e. What was the effect on mortality from coronary heart disease? Can the answer be A.Please discuss.
test123 Forum Newbie
Topics: 5 Posts: 16
10/03/07 - 09:57 AM
#2
can someone discuss this Q please?
Jackofknives Ipwnpoker.com
Topics: 91 Posts: 708
10/03/07 - 11:08 AM
#3
IMO its A, bc if it wasnt blinded then there is no point asking the rest of the questions. ___________________ There are many things in this world that can’t be changed no matter how hard you try. That’s why you must not hesitate when the time comes where you have to give it all you’ve got.
